These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 31348230)

  • 1. E-cadherin expression is associated with susceptibility and clinicopathological characteristics of thyroid cancer: A PRISMA-compliant meta-analysis.
    Zhou C; Yang C; Chong D
    Medicine (Baltimore); 2019 Jul; 98(30):e16187. PubMed ID: 31348230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concomitant high expression of BRAFV600E, P-cadherin and cadherin 6 is associated with High TNM stage and lymph node metastasis in conventional papillary thyroid carcinoma.
    Zhao L; Jiang R; Xu M; Zhu P; Mo XM; Wang N; Chen GG; Liu ZM
    Clin Endocrinol (Oxf); 2016 May; 84(5):748-55. PubMed ID: 26285159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of E-cadherin expression in thyroid neoplasms.
    Naito A; Iwase H; Kuzushima T; Nakamura T; Kobayashi S
    J Surg Oncol; 2001 Mar; 76(3):176-80. PubMed ID: 11276021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression of E-cadherin in thyroid neoplastic tissues and its correlation with malignant and metastatic potential].
    Naitoh A; Kobayashi S; Iwase H; Kuzushima T
    Nihon Rinsho; 1995 Jul; 53(7):1619-22. PubMed ID: 7629998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TERT promoter Mutation and Its Association with Clinicopathological Features and Prognosis of Papillary Thyroid Cancer: A Meta-analysis.
    Liu C; Liu Z; Chen T; Zeng W; Guo Y; Huang T
    Sci Rep; 2016 Nov; 6():36990. PubMed ID: 27833153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pathologic study of expression and significance of matrix metalloproteinases-9, tissue inhibitor of metalloproteinase-1, vascular endothelial growth factor and transforming growth factor beta-1 in papillary carcinoma and follicular carcinoma of thyroid].
    Wang T; Jiang CX; Li Y; Liu X
    Zhonghua Bing Li Xue Za Zhi; 2009 Dec; 38(12):824-8. PubMed ID: 20193458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced expression of E-cadherin correlates with poor prognosis and unfavorable clinicopathological features in gastric carcinoma: a meta-analysis.
    Lu G; Cai Z; Jiang R; Tong F; Tu J; Chen Y; Fu Y; Sun J; Zhang T
    Aging (Albany NY); 2024 Jun; 16(12):10271-10298. PubMed ID: 38870263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of E-cadherin as a prognostic marker in thyroid carcinomas.
    Scheumman GF; Hoang-Vu C; Cetin Y; Gimm O; Behrends J; von Wasielewski R; Georgii A; Birchmeier W; von Zur Mühlen A; Dralle H
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2168-72. PubMed ID: 7608273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Number of tumor foci as predictor of lateral lymph node metastasis in papillary thyroid carcinoma.
    Kim HJ; Park HK; Byun DW; Suh K; Yoo MH; Min YK; Kim SW; Chung JH
    Head Neck; 2015 May; 37(5):650-4. PubMed ID: 24590814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of two tumor foci for predicting central lymph node metastasis in papillary thyroid carcinoma: A meta-analysis.
    Feng J; Gan X; Shen F; Cai W; Xu B
    Int J Surg; 2018 Apr; 52():166-170. PubMed ID: 29481991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The study of the correlation of papillary thyroid carcinoma's invasion toward Ezrin and E-cadherin].
    Liu C; Chen X; Gao Z; Liu Z; Tao X
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Sep; 26(17):789-91, 795. PubMed ID: 23214316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
    Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E-cadherin/α-catenin deregulated co-expression in thyroid carcinoma based on tissue microarray digital image analysis.
    Tsiambas E; Ragos V; Georgakopoulos G; Rigopoulos DN; Fotiades PP; Chatziioannidis A; Stamatelopoulos A; Vilaras G; Karameris A
    J BUON; 2016; 21(2):450-5. PubMed ID: 27273957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic and Clinicopathological Significance of E-Cadherin in Pancreatic Cancer Patients: A Meta-Analysis.
    Wang P; Zhu Z
    Front Oncol; 2021; 11():627116. PubMed ID: 33912451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk Patterns of Distant Metastases in Follicular, Papillary and Medullary Thyroid Cancer.
    Machens A; Lorenz K; Weber F; Dralle H
    Horm Metab Res; 2022 Jan; 54(1):7-11. PubMed ID: 34758495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison between unifocal papillary thyroid microcarcinoma with noninvasive follicular thyroid neoplasm with papillary-like nuclear features and other patterns: A retrospective clinicopathological study.
    Cakir E; Saygin I; Kisioglu S
    Indian J Pathol Microbiol; 2020; 63(2):188-193. PubMed ID: 32317513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic markers in well differentiated papillary and follicular thyroid cancer (WDTC).
    Gillanders SL; O'Neill JP
    Eur J Surg Oncol; 2018 Mar; 44(3):286-296. PubMed ID: 28801060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Papillary thyroid carcinoma located in the isthmus or upper third is associated with Delphian lymph node metastasis.
    Chai YJ; Kim SJ; Choi JY; Koo do H; Lee KE; Youn YK
    World J Surg; 2014 Jun; 38(6):1306-11. PubMed ID: 24366273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression of EpCAM and E-cadherin in papillary thyroid carcinoma and its clinicopathologic significance].
    Cheng Y; Meng Y; Liang Z; Yang C; Luo Y; Cui Q
    Zhonghua Bing Li Xue Za Zhi; 2015 Mar; 44(3):189-94. PubMed ID: 26268754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathologic Factors and Thyroid Nodule Sonographic Features for Predicting Central Lymph Node Metastasis in Papillary Thyroid Microcarcinoma: A Retrospective Study of 1204 Patients.
    Wang WH; Xu SY; Zhan WW
    J Ultrasound Med; 2016 Nov; 35(11):2475-2481. PubMed ID: 27794131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.